Temperature-controlled logistics company Cryoport, has been selected by allogeneic cell therapy company, Celularity, to utilize its complete range of temperature-controlled solutions.   Celularity is a clinical-stage cell therapeutics company developing allogeneic cellular therapies harnessed from human placentas through its proprietary IMPACT platform across immuno-oncology, inflammatory and age-related diseases. The agreement will give Celularity access to Cryoport’s full suite of temperature-...